Table 1.
Association between the expression of DTL and clinicopathological characteristics.
| Variable | Total patients | DTL expression | p | |
|---|---|---|---|---|
| No (%) | Low | High | ||
| Age, mean ± SD (years) | 65.2 ± 12 | 61.9 ± 12.5 | 68.5 ± 10.5 | 0.0003 |
| Age | 0.0004 | |||
| <65 | 74 (44.8%) | 49 (59.0%) | 25 (30.5%) | |
| ≥65 | 91 (55.2%) | 34 (41.0%) | 57 (69.5%) | |
| Gender | 0.024 | |||
| Male | 135 (81.8%) | 74 (89.2%) | 61 (74.4%) | |
| Female | 30 (18.2%) | 9 (10.8%) | 21 (25.6%) | |
| Invasiveness | 0.005 | |||
| Superficial | 103 (62.4%) | 61 (73.5%) | 42 (51.2%) | |
| Invasive | 62 (37.6%) | 22 (26.5%) | 40 (48.8%) | |
| Lymphatic metastasis | 0.03 | |||
| No | 149 (90.3%) | 79 (95.2%) | 70 (85.4%) | |
| Yes | 15 (9.1%) | 3 (3.6%) | 12 (14.6%) | |
| T stage | 0.004 | |||
| Ta | 24 (14.5%) | 19 (22.9%) | 5 (6.1%) | |
| T1 | 80 (48.5%) | 42 (50.6%) | 38 (46.3%) | |
| T2 | 31 (18.8%) | 13 (15.7%) | 18 (22.0%) | |
| T3 | 19 (11.5%) | 4 (4.8%) | 15 (18.3%) | |
| T4 | 11 (6.7%) | 5 (6.0%) | 6 (7.3%) | |
| Grade | 2.01e − 06 | |||
| Low | 105 (63.6%) | 68 (81.9%) | 37 (45.1%) | |
| High | 60 (36.4%) | 15 (18.1%) | 45 (54.9%) | |